Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Meriranta
Young High Risk Patients With Diffuse Large B-Cell Lymphoma Including BCL-2/Myc Double Hit Lymphomas Benefit From Dose-Dense Immunochemotherapy With Early CNS Prophylaxis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Prophylaxis With High-Dose Methotrexate Significantly Reduces CNS Dissemination in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) and High-Risk CNS-IPI Score
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
BCL-2 Protein Frequency in Patients With High-Risk Diffuse Large B-Cell Lymphoma
Sao Paulo Medical Journal
Medicine
Combination of BCL-2 and MYC Protein Expression Improves High-Risk Stratification in Diffuse Large B-Cell Lymphoma
OncoTargets and Therapy
Oncology
Pharmacology
The Double Hit Signature Identifies Double-Hit Diffuse Large B-Cell Lymphoma With Genetic Events Cryptic to FISH
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Immunochemoradiotherapy or Immunochemotherapy Only in Patients With Extranonal Diffuse Large B-Cell Lymphoma of Stomach
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Double-Hit B-Cell Lymphomas
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Plasma Immunoprofiling of Patients With High-Risk Diffuse Large B-Cell Lymphoma: A Nordic Lymphoma Group Study
Blood Cancer Journal
Oncology
Hematology
